Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up 0.80% Nasdaq Up 0.97%
Streaming
Ticker Tape: On

More On UCBJF

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates
  • Research Reports

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

UCB SA (UCBJF)

-OTC Markets

60.00 0.00(0.00%) May 8, 10:11AM EDT

Add to Portfolio
Prev Close:60.00
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:48.35 - 63.84
Volume:0
Avg Vol (3m):43
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):N/A
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for UCBJF at this time.

Reports

  • No Reports available for UCBJF at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

UCB S.A., a biopharmaceutical company, discovers and develops therapies primarily for central nervous system (CNS) disorders and immunology diseases worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback